CBD brand Pureis®, founded by Loughrea woman Chanelle McCoy, has this week become the frist CBD product to gain a Positive Safety Assessment from the UK’s Food Standards Agency. This endorsement from the FSA Scientific Committee indicates that Pureis® Ultra Pure CBD has successfully fulfilled the rigorous criteria necessary to progress to the final stage of the Novel Food Licensing process.
The UK is the first authority globally to conclude and publish safety assessments for CBD food supplement products. Pureis® has also been approved by the US Food and Drug Administration.
“This is a monumental achievement and a complete game-changer for the CBD industry,” said Chanelle McCoy, CEO of Chanelle McCoy Health, the brand owner of Pureis®. “We are thrilled Pureis® is the first CBD brand globally to receive this Positive Safety Assessment officially from a leading regulatory authority. Unwavering in our pursuit of excellence, we’re positively shaping the CBD industry with compliant, science-backed products.
Pureis® and other CBD brands are made with cannabidiol, a derivative of cannabis which is believed to have health benefits. Unlike tetrahydrocannabinol (THC ), the active ingredient in cannabis, CBD is not addictive and does not produce a psychoactive effect or ‘high’. Pureis®, which has been rirgourously tested while in development for more than a decade, contains 0 per cent THC, and no pollutants, toxins, terpenes, heavy metals, pesticides and other cannabinoids that can occur naturally in the cannabis plant.
CBD is classified as a Novel Food, which refers to food products that are either entirely new or produced using methods not previously used for human consumption. The latter category includes CBD, as it’s a relatively recent addition to the mainstream food market. In Ireland, novel foods are overseen by the European Commission and the Food Safety Authority of Ireland.
A Novel Food authorisation/approval requires extensive safety studies to be carried out by internationally recognized clinical research organisations adhering to good laboratory practice and good clinical practice principles. This includes clinical testing to ensure product purity and consistency, and toxicological evaluations to comply to all the consumer safety requirements.
Pureis® is also under registration in over 40 countries globally registering its lab-made ultra pure CBD as a food supplement.
Chanelle McCoy is a member of the Burke family, founders of Chanelle Pharma in Loughrea which was sold earlier this year. Her own business interests include Chanelle McCoy Health, which produces a number of products including Pureis®. She also appeared as a Dragon on the Irish version of Dragon’s Den. She is married to former champion jockey AP McCoy.
